| Literature DB >> 23597389 |
Delphine Pessoa, Fabian Hoti, Ritva Syrjänen, Raquel Sá-Leão, Tarja Kaijalainen, M Gabriela M Gomes, Kari Auranen.
Abstract
BACKGROUND: Day-care centre (DCC) attendees play a central role in maintaining the circulation of Streptococcus pneumoniae (pneumococcus) in the population. The prevalence of pneumococcal carriage is highest in DCC attendees but varies across countries and is found to be consistently lower in Finland than in Portugal. We compared key parameters underlying pneumococcal transmission in DCCs to understand which of these contributed to the observed differences in carriage prevalence.Entities:
Mesh:
Year: 2013 PMID: 23597389 PMCID: PMC3652738 DOI: 10.1186/1471-2334-13-180
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Figure 1Trace plot for the Markov chain Monte Carlo samples. A. Portuguese data. B. Finnish data. Three independent Markov chains are presented. The horizontal lines present the crude estimates of the parameters. The log-likelihood at each iteration is calculated from the joint likelihood of the parameter (sample) values, based on the children’s current (augmented) histories.
Numbers of carriage samples and pneumococcal isolates by day-care room
| | | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | |||||||||
| Number of children enrolled (/attendees) | 16 (/16) | 15 (/15) | 16 (/16) | 8 (/12) | 17 (/22) | 5 (/19) | 5 (/21) | 8 (/28) | 12 (/23) | 6 (/22) | 108 (/194) |
| 19F | 38 | 24 | 26 | 0 | 0 | 3 | 8 | 3 | 0 | 0 | 102 |
| 23F | 6 | 30 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39 |
| 6B | 6 | 0 | 23 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 31 |
| 14 | 1 | 8 | 13 | 0 | 0 | 0 | 1 | 1 | 0 | 2 | 26 |
| 9V | 7 | 0 | 1 | 6 | 12 | 0 | 0 | 0 | 0 | 0 | 26 |
| 19A | 6 | 7 | 1 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 22 |
| 3 | 0 | 0 | 0 | 0 | 12 | 2 | 0 | 0 | 4 | 3 | 21 |
| 10A | 7 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 |
| 18C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 2 | 20 |
| 15B/C | 0 | 0 | 0 | 0 | 4 | 0 | 1 | 5 | 4 | 3 | 17 |
| Non-typeable | 4 | 3 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 |
| 11A | 5 | 0 | 0 | 0 | 1 | 0 | 4 | 0 | 2 | 2 | 14 |
| 35F | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 2 | 0 | 0 | 7 |
| 16F | 2 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| 18F | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| 22 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 0 | 0 | 0 | 5 |
| 38 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 3 |
| 15A | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 33 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 |
| 6A | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 2 |
| 10 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 16 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| 18B | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| 23B | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 35B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 9N | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Total isolates (% samples) | 87 (64%) | 79 (64%) | 88 (57%) | 12 (17%) | 45 (31%) | 8 (16%) | 18 (37%) | 12 (24%) | 30 (25%) | 13 (22%) | 392 |
| Negative samples | 50 | 45 | 67 | 60 | 98 | 42 | 31 | 37 | 89 | 46 | 565 |
| Total samples | 137 | 124 | 155 | 72 | 143 | 50 | 49 | 49 | 119 | 59 | 957 |
The Portuguese day-care centre had three rooms (P1, P2, P3) and the three Finnish day-care centres (DCC1, DCC2, DCC3) had altogether 7 rooms (F1,…,F7).
Figure 2Serotype distribution within day-care rooms. In each room, serotypes are ranked from the most common to the least common one. There are 3 rooms (P1, P2, P3) in the Portuguese and seven rooms (F1,…,F7) in the Finnish datasets, respectively. The actual identity of each of the serotypes per room can be retrieved from Table 1.
Figure 3Observed numbers of isolates for the most common serotypes by day-care room and visit. For each room, only serotypes responsible for more than 20% of positive samples in that room are shown. The numbers of enrolled children in each room are indicated in the parentheses.
Acquisition and clearance of carriage in a day-care centre in Portugal, 1998–1999
| | |||||||
|---|---|---|---|---|---|---|---|
| 19F | Yes | 19 | 58 | 17 | 96 | 5 | 85 |
| No | 2 | 2 | 3 | 19 | 0 | 20 | |
| 23F | Yes | 10 | 23 | 10 | 47 | 2 | 54 |
| No | 1 | 3 | 2 | 68 | 1 | 85 | |
| 6B | Yes | 2 | 13 | 5 | 44 | 5 | 61 |
| No | 3 | 7 | 2 | 71 | 3 | 84 | |
| 14 | Yes | 2 | 10 | 3 | 17 | 6 | 27 |
| No | 0 | 0 | 2 | 98 | 4 | 128 | |
| 10A | Yes | 2 | 11 | 1 | 27 | 1 | 44 |
| No | 2 | 2 | 4 | 88 | 5 | 108 | |
| 19A | Yes | 3 | 7 | 1 | 33 | 0 | 37 |
| No | 2 | 4 | 2 | 82 | 2 | 117 | |
| NT | Yes | 1 | 5 | 1 | 44 | 3 | 52 |
| No | 1 | 6 | 1 | 71 | 3 | 102 | |
| 16F | Yes | 0 | 0 | 0 | 18 | 0 | 21 |
| No | 1 | 2 | 2 | 97 | 3 | 142 | |
| 18F | Yes | 1 | 1 | 1 | 4 | 0 | 7 |
| No | 0 | 0 | 1 | 111 | 2 | 157 | |
| 11A | Yes | 0 | 0 | 0 | 13 | 1 | 25 |
| No | 2 | 3 | 0 | 102 | 0 | 137 | |
| 23B | Yes | 0 | 0 | 0 | 6 | 0 | 4 |
| No | 1 | 1 | 1 | 109 | 0 | 160 | |
| 9V | Yes | 0 | 2 | 0 | 21 | 1 | 34 |
| No | 0 | 4 | 1 | 94 | 0 | 125 | |
| 15A | Yes | 0 | 0 | 0 | 4 | 0 | 7 |
| No | 0 | 1 | 1 | 111 | 0 | 157 | |
| 8 | Yes | 0 | 0 | 0 | 0 | 0 | 0 |
| No | 0 | 0 | 0 | 115 | 1 | 165 | |
| Total: | Yes | 40 | 130 | 39 | 374 | 24 | 458 |
| No | 15 | 35 | 22 | 1236 | 24 | 1687 | |
| 55 | 165 | 78 | 1610 | 48 | 2145 | ||
The crude estimates of the model parameters are (cf. Appendix): the transmission rate (per month); the community acquisition rate per serotype (in non-carrying children) (per month); the clearance rate of carriage (per month); the competition parameter . For parameter β, the denominator (60.18) is not directly readable from the data as presented in the table. Only samples available from two consecutive visits were considered, accounting for 67% of the scheduled pairs of consecutive visits. The three rooms were analysed as six rooms, separated by the summer break.
1 Exposure is here defined as the presence of at least one carrier of the target serotype in the other attendees in the room.
2 Person-time here is the total time, in months, spent carrying pneumococcus overall (total row) or a specific serotype (serotype rows) stratified by the presence or absence of other carriers of the specific serotype.
3 Person-time here is the total time, in months, spent as a non-carrier, stratified by exposure to the specific serotype. For the total row, the time is a sum of serotype-specific person-times.
4 As in 2 but for children carrying pneumococcus.
Acquisition and clearance of carriage in 3 day-care centres in Finland, 2001–2002
| | |||||||
|---|---|---|---|---|---|---|---|
| 9V | Yes | 7 | 12 | 7 | 56 | 1 | 14 |
| No | 3 | 3 | 6 | 300 | 1 | 83 | |
| 18C | Yes | 7 | 16 | 9 | 87 | 0 | 11 |
| No | 4 | 4 | 1 | 269 | 0 | 81 | |
| 3 | Yes | 1 | 3 | 6 | 105 | 1 | 30 |
| No | 8 | 11 | 4 | 251 | 0 | 68 | |
| 15BC | Yes | 1 | 4 | 1 | 77 | 0 | 19 |
| No | 5 | 12 | 7 | 279 | 0 | 77 | |
| 19A | Yes | 4 | 5 | 0 | 35 | 0 | 8 |
| No | 3 | 3 | 2 | 321 | 0 | 96 | |
| 19F | Yes | 2 | 3 | 1 | 28 | 1 | 8 |
| No | 2 | 8 | 2 | 328 | 1 | 93 | |
| 11A | Yes | 2 | 2 | 0 | 18 | 0 | 8 |
| No | 0 | 4 | 1 | 338 | 5 | 98 | |
| 14 | Yes | 0 | 0 | 0 | 12 | 0 | 5 |
| No | 3 | 4 | 2 | 344 | 1 | 103 | |
| 35F | Yes | 0 | 1 | 1 | 40 | 0 | 13 |
| No | 1 | 3 | 1 | 316 | 2 | 95 | |
| 38 | Yes | 0 | 0 | 0 | 24 | 0 | 13 |
| No | 2 | 3 | 2 | 332 | 0 | 96 | |
| 22 | Yes | 0 | 0 | 0 | 20 | 0 | 0 |
| No | 1 | 5 | 0 | 336 | 2 | 107 | |
| 33 | Yes | 0 | 0 | 0 | 0 | 0 | 0 |
| No | 0 | 0 | 2 | 356 | 0 | 112 | |
| 6A | Yes | 0 | 0 | 0 | 8 | 0 | 6 |
| No | 1 | 1 | 1 | 348 | 0 | 105 | |
| 6B | Yes | 0 | 0 | 0 | 12 | 0 | 7 |
| No | 1 | 2 | 1 | 344 | 0 | 103 | |
| 7 | Yes | 0 | 0 | 0 | 9 | 0 | 1 |
| No | 1 | 1 | 1 | 347 | 0 | 110 | |
| 10 | Yes | 0 | 0 | 0 | 4 | 0 | 2 |
| No | 1 | 1 | 0 | 352 | 0 | 109 | |
| 18B | Yes | 0 | 0 | 0 | 3 | 0 | 1 |
| No | 1 | 1 | 0 | 353 | 0 | 110 | |
| 35B | Yes | 0 | 0 | 0 | 0 | 0 | 0 |
| No | 0 | 0 | 1 | 356 | 0 | 112 | |
| 9N | Yes | 0 | 0 | 0 | 0 | 0 | 0 |
| No | 0 | 0 | 1 | 356 | 0 | 112 | |
| 165 | Yes | 0 | 0 | 0 | 7 | 0 | 4 |
| No | 0 | 0 | 0 | 349 | 0 | 108 | |
| Total: | Yes | 24 | 46 | 25 | 545 | 3 | 150 |
| No | 37 | 66 | 35 | 6575 | 12 | 1978 | |
| 61 | 112 | 60 | 7120 | 15 | 2128 | ||
The crude estimates of the model parameters are (cf. Appendix): the transmission rate (per month); the community acquisition rate per serotype (in non-carrying children) (per month); the clearance rate of carriage (per month); the competition parameter . For parameter β, the denominator (85.26) is not directly readable from the data as presented in the table. Only samples from two consecutive visits were considered (85% of the scheduled pairs of consecutive visits).
1 Exposure is here defined as the presence of at least one carrier of the target serotype in the other attendees in the room.
2 Person-time here is the total time, in months, spent carrying pneumococcus overall (total row) or a specific serotype (serotype rows) stratified by the presence or absence of other carriers of the specific serotype.
3 Person-time here is the total time, in months, spent as a non-carrier, stratified by exposure to the specific serotype. For the total row, the time is a sum of serotype-specific person-times.
4 As in 2 but for children carrying pneumococcus.
5 Sampled only once in a child which was missing at the next visit.
Estimates of the model parameters
| Transmission rate ( | 0.54 | 1.05 | (0.82; 1.31) | 0.26 | 0.63 | (0.47; 0.79) |
| Overall community acquisition rate ( | 0.25 | 0.25 | (0.18; 0.34) | 0.11 | 0.12 | (0.09; 0.15) |
| Clearance rate ( | 0.33 | 0.57 | (0.51; 0.65) | 0.54 | 0.73 | (0.66; 0.81) |
| Competition ( | 0.80 | 0.51 | (0.30; 0.77) | 1.14 | 0.67 | (0.22; 1.26) |
Crude estimates and posterior means and 90% credible intervals (CI) for the four model parameters from the adjusted (full) model. The rate parameters are presented per month. The mean durations of carriage (time until immune clearance) corresponding to the crude exponential clearance rates are 3 months and 1.9 months for the Portuguese and Finnish datasets, respectively. Based on the adjusted analysis and the Weibull clearance rates, the mean durations are 1.6 months in Portugal (90% CI: 1.4-1.8 months) and 1.2 months in Finland (90% CI: 1.1-1.4 months).
Figure 4Posterior distributions of the model parameters. The rate parameters are presented per month.
Figure 5Model checking. The figure presents the posterior predictive distributions of carriage prevalence (panel A) and crude transition rates (panel B: acquisition in non-carriers; panel C: acquisition in non-carriers; panel D: clearance). The vertical lines show the actually observed carriage prevalence and crude transition rates. Note that the acquisition rates are not conditioned on exposure (panels B and C).